BILLERICA, Mass. -- (BUSINESS WIRE) -- Belmont Instrument Corporation announced this week that the Belmont® Rapid Infuser has been approved for use in Japan and will begin distributing the device through its partnership with Mediconovus Ltd. of Yokohama. The Belmont® Rapid Infuser is recognized as the standard of care for the treatment of massive blood loss in hospitals throughout the world.
The Belmont® Rapid Infuser, manufactured at the Belmont Instrument facility in Billerica, MA, combines advanced fluid heating and control technology to infuse large amounts of vital fluids warmed to physiological temperature at flow rates up to 1 L/min. The Rapid Infuser is equipped with multiple air, temperature, and pressure sensors to protect the patient, and to ensure the safety and efficacy of the infusion process.
This life-saving device has been used in over 420,000 procedures in more than 50 countries. There are currently more than 3,500 systems in use throughout the world. The Belmont® Rapid Infuser has been used extensively by the U.S. military and by many foreign medical teams in Iraq and Afghanistan and has been credited with helping to save the lives of hundreds of soldiers and civilians.
Belmont Instrument Corporation has developed sophisticated and reliable devices for massive transfusion, temperature management, and cardiac assist since its founding in 1980.